Improvement of Sarcopenia in Patients Following Two Different Diets
NCT ID: NCT03405727
Last Updated: 2020-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2018-03-20
2018-09-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Protein intake is very important when treating sarcopenia. However, meeting the protein requirements at home proves difficult. Oral dietary supplements, given in addition to the other known recommendations, might provide a solution.
This study will assess the efficacy of the oral dietary supplements for the treatment of sarcopenia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sarcopenia Prevention With a Targeted Exercise and Protein Supplementation Program
NCT03417531
Intervention Assessing the Role of Exercise Program and Nutrition Supplement for Sarcopenia
NCT02374268
The Effect of a Multi-intervention Program and Protein Food Sources on Preventing and Mitigating Sarcopenia
NCT06173271
Combined Effects of Resistance Training and Nutritional Supplements in the Treatment of Sarcopenia
NCT00748696
Nutrition and Exercise for Sarcopenia
NCT00872911
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard treatment
No interventions assigned to this group
Oral dietary supplements
Oral dietary supplements
Protein enriched diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral dietary supplements
Protein enriched diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with sarcopenia (by means of a dynamometer)
* Patients having stayed in an intensive care unit for longer than 5 weeks
Exclusion Criteria
* Anorexic patients
* Patients having a life expectancy of less than 6 months
* Demented patients
* BPCO patients
* Patients with neuropathies
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brugmann University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tatiana Besse-Hammer
Head of clinic
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Turkan Dalgic
Role: PRINCIPAL_INVESTIGATOR
Haute Ecole Lucia De Brouckère
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Brugmann
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUB-diet
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.